VERT 发表于 2025-3-23 10:24:04

Submitted on: 04 September 2005.
Revised on: 22 September 2005.
Accepted on: 17 October 2005.
NUCLEAR MEDICINE COMMUNICATIONS

诗集 发表于 2025-3-23 17:52:58

http://reply.papertrans.cn/3/234/23366/23366-12.png

doxazosin 发表于 2025-3-23 19:33:02

http://reply.papertrans.cn/3/234/23366/23366-13.png

蒸发 发表于 2025-3-23 23:03:47

Submitted on: 26 July 2018.
Revised on: 21 August 2018.
Accepted on: 14 September 2018.
NUCLEAR MEDICINE COMMUNICATIONS

红润 发表于 2025-3-24 05:19:23

http://reply.papertrans.cn/3/234/23366/23366-15.png

Mercantile 发表于 2025-3-24 06:38:21

http://reply.papertrans.cn/3/234/23366/23366-16.png

高兴一回 发表于 2025-3-24 13:55:58

http://reply.papertrans.cn/3/234/23366/23366-17.png

Mhc-Molecule 发表于 2025-3-24 15:29:22

http://reply.papertrans.cn/3/234/23366/23366-18.png

摊位 发表于 2025-3-24 20:34:14

Submitted on: 25 February 2002.
Revised on: 12 March 2002.
Accepted on: 21 March 2002.
NUCLEAR MEDICINE COMMUNICATIONS

pellagra 发表于 2025-3-24 23:12:43

Submitted on: 18 September 2019.
Revised on: 24 October 2019.
Accepted on: 19 November 2019.
NUCLEAR MEDICINE COMMUNICATIONS
页: 1 [2] 3 4
查看完整版本: SCIE期刊NUCLEAR MEDICINE COMMUNICATIONS 2024/2025影响因子:1.376 (NUCL MED COMMUN) (0143-3636). (RADIOLOGY, NUCLEAR MEDICINE &